3 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
11 Sep 23
Enlivex Announces Reprioritization Plan and Second Quarter 2023 Financial Results
8:00am
been at the heart of our mission,” said Oren Hershkovitz, Ph.D., CEO of Enlivex. “While we have made significant progress in our oncology research
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
5 Mar 20
Report of Foreign Private Issuer
8:16am
Exhibit 99.1
Enlivex Therapeutics Confirms Public Statements Made by the Head of Israel Economic and Commercial Mission to South KoreaRegarding … , today confirmed the public statements made by the Head of Israel Economic and Commercial Mission to South Korea, regarding a proposal submitted
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
2 Feb 15
Bio Blast Announces Key Leadership Changes
12:00am
, as well as having a wealth of experience advising companies across the continuum of mission critical functions from business development to corporate
- Prev
- 1
- Next